What is Eli Lilly's china — revenue?

Eli Lilly (LLY) reported china — revenue of $693M in Q1 2026.

How has Eli Lilly's china — revenue changed year-over-year?

Eli Lilly's china — revenue increased by 53.7% year-over-year, from $451M to $693M.

What is the long-term trend for Eli Lilly's china — revenue?

Over 4 years (2021 to 2025), Eli Lilly's china — revenue has grown at a 4.1% compound annual growth rate (CAGR), from $1.66B to $1.95B.

Eli Lilly LLY China — Revenue

Other geography segments

U.S.

$5.18B—

Japan

$534.8M—

Other financials

Income statement

See full

Revenue$19.8B+55.5%

Gross profit$16.2B+54.4%

Net income$7.4B+168%

EPS (diluted)$8.26+170%

Balance sheet

See full

Cash & equivalents$5.3B+70.8%

Total debt$43.4B+12.6%

Total equity$31.2B+97.9%

Total assets$116.58B+30.4%

Cash flow

See full

Operating cash flow$5.3B+220%

CapEx$2.3B+54.0%

Free cash flow$3.0B+1,828%

Valuation

See full

Market cap$1.09T+56.4%

Enterprise value$1.12T+53.8%

P/E42.9×-7.3×

P/S15×+2.0×

Profitability

See full

Gross margin82.8%+1.1pp

Net margin35%+12.3pp

FCF margin16.4%+8.7pp

Returns & leverage

See full

Return on equity107.6%+29.9pp

Debt / equity1.4×-1.1×

Current ratio1.5×+0.1×

Where this comes from

Reported directly by Eli Lilly in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The official record: Eli Lilly’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Eli Lilly's china — revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Eli Lilly's china — revenue?: Eli Lilly (LLY) reported china — revenue of $693M in Q1 2026.
How has Eli Lilly's china — revenue changed year-over-year?: Eli Lilly's china — revenue increased by 53.7% year-over-year, from $451M to $693M.
What is the long-term trend for Eli Lilly's china — revenue?: Over 4 years (2021 to 2025), Eli Lilly's china — revenue has grown at a 4.1% compound annual growth rate (CAGR), from $1.66B to $1.95B.